Clinical Trial

Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 30, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-20.
Status change: Not Yet Recruiting → Recruiting 2025-05-29
Trial Details
NCT Number NCT06993922
Lead Sponsor Ain Shams University
Conditions Dexmedetomidine, Adjuvant, Bupivacaine, Scalp Block, Postoperative Pain, Craniotomy
Enrollment 50 participants
Start Date 2025-05-29
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-30